Evidence map›Paper›PMID 27716346›Full record

ReviewCritical care (London, England)2016

Fundamentals of aerosol therapy in critical care.

Jayesh Dhanani, John F Fraser, Hak-Kim Chan, Jordi Rello, Jeremy Cohen, Jason A Roberts

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03597334 (Aerosol Therapy in Intensive Care Units), which is not on this map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03597334 completednot on this mapstarted 2018, after this paper: background citation

Aerosol Therapy in Intensive Care Units: a Prospective Observation Study

Typeobservational_patient_registrySponsorlvshanRan2018 to 2018Enrolled1,095ConditionsRespiration, Artificial, Critical CareArmsaerosol therapy
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Nebuliser therapy in critical care: The past, present and future.Journal of the Intensive Care Society · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jayesh DhananiBurns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. Jayesh.Dhanani@health.qld.gov.au.ORCID 0000-0001-9803-9701
John F FraserDepartment of Intensive Care Medicine, The Prince Charles Hospital, Brisbane, Australia.
Hak-Kim ChanAdvanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Jordi RelloCritical Care Department, Hospital Vall d'Hebron, Barcelona, Spain.
Jeremy CohenBurns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.
Jason A RobertsBurns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.
The University of Queensland · AUQueensland Health · AUThe University of Sydney · AUUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug dosing in critically ill patients is challenging due to the altered drug pharmacokinetics-pharmacodynamics associated with systemic therapies. For many drug therapies, there is potential to use the respiratory system as an alternative route for drug delivery. Aerosol drug delivery can provide many advantages over conventional therapy. Given that respiratory diseases are the commonest causes of critical illness, use of aerosol therapy to provide high local drug concentrations with minimal systemic side effects makes this route an attractive option. To date, limited evidence has restricted its wider application. The efficacy of aerosol drug therapy depends on drug-related factors (particle size, molecular weight), device factors, patient-related factors (airway anatomy, inhalation patterns) and mechanical ventilation-related factors (humidification, airway). This review identifies the relevant factors which require attention for optimization of aerosol drug delivery that can achieve better drug concentrations at the target sites and potentially improve clinical outcomes.

Indexed as

Administration, InhalationNebulizers and VaporizersCritical CareDrug Delivery SystemsEquipment DesignHeliumHumansOxygenParticle SizePatient PositioningRespiration, ArtificialhelioxHeliumOxygen

Identifiers

PMID27716346
PMCPMC5054555
OpenAlexW2509925901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.